| Title |
Indacaterol for Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis
|
|---|---|
| Published in |
PLOS ONE, August 2013
|
| DOI | 10.1371/journal.pone.0070784 |
| Pubmed ID | |
| Authors |
Vincent C. H. Chung, Polly H. X., David S. C. Hui, Wilson W. S. Tam, Jin Ling Tang |
| Abstract |
Inhaled bronchodilators are the first-line therapy for COPD. Indacaterol is a novel addition to existing long-acting bronchodilators. |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 3% |
| Unknown | 39 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 18% |
| Student > Master | 7 | 18% |
| Student > Bachelor | 5 | 13% |
| Other | 5 | 13% |
| Student > Postgraduate | 4 | 10% |
| Other | 9 | 23% |
| Unknown | 3 | 8% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 55% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 8% |
| Psychology | 2 | 5% |
| Biochemistry, Genetics and Molecular Biology | 1 | 3% |
| Nursing and Health Professions | 1 | 3% |
| Other | 4 | 10% |
| Unknown | 7 | 18% |